 |
Quick Links |
| Information by Disease |
|
|
 |
| Cancer News |
|
|
 |
| Conference Coverage |
|
|
 |
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
 |
Neuroblastoma
| Accutane (isotretinoin) |
Retinoid |
Roche |
III |
| Chimeric MAb14.18 |
Anti-GD2 monoclonal antibody |
NCI |
III |
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|